Article
Targeting gastrin releasing peptide receptors: New options for the therapy and diagnosis of cancer
1 May 2010
Abstract excerpt
Gastrin-releasing peptide (GRP), the mammalian bombesin (BN), appears to be involved in the growth of several neoplasms. BN/GRP receptors (BN/GRP-Rs) are expressed in a variety of cancer cells and have limited distribution in normal human tissue. Thus inhibition of BN/GRP-Rs represents an attractive target for pharmacological treatment of some human malignancies. This review will focus on intracellular signaling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
